Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus
Diabetes & Vascular Disease Research · 2026-07 · 23 (4)
DOI: 10.1177/14791641251398558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Vascular Disease Research, online erschienen am 28.07.2026. Verfasst von Manel Salsabil Alakrab und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, University of Monastir, Monastir, Tunisia. Hauptthemen laut MEDLINE: Diabetes, Gestational, Glycation End Products, Advanced, Blood Glucose, Skin. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Advanced glycation end products (AGEs) can be measured non-invasively through skin autofluorescence (SAF). Studies on SAF in gestational diabetes mellitus (GDM) remain limited. This study aims to evaluate SAF in Tunisian pregnant women with GDM and its association with the requirement for insulin therapy.
Methods
A cross sectional study was conducted of 242 pregnant women who visited at the Monastir-Tunisia Center for Maternity. Screening for GDM was performed using the OGTT. 200 pregnant women were included in the study with and without GDM. We measured SAF using the AGE reader Mu device and the age-adjusted SAF-z score was calculated.
Results
Higher SAF levels and SAF-z scores were observed in pregnant women with GDM compared to healthy controls (2.1 ± 0.5 AU vs 1.9 ± 0.4 AU p < 0.001, 1.02 ± 0.9 vs 0.64 ± 0.7 p = 0.002, respectively). The ROC analysis revealed that an SAF >2.3 AU was the optimal cut-off point for predicting insulin therapy requirement with a sensitivity of 90.9% and a specificity of 69.7% ( p < 0.001).
Conclusion
SAF was increased in GDM, and can be a biomarker associated suboptimal glycemic control in pregnant women with GDM. Our findings highlight the relevance of SAF measurement and suggest SAF monitoring during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Research on Biologically Compatible Compounds, Faculty of Dental Medicine, University of Monastir, Monastir, Tunisia.
- Department of Obstetric and Gynecology, University Hospital Fattouma Bourguiba of Monastir, Monastir, Tunisia.
ORCID-Profile: Mohsen Kerkeni
Zitieren
APA
Alakrab, M. S., Toumi, D., Selmi, A., Hajji, A., Zoukar, O., Abid, S., Faleh, R., & Kerkeni, M. (2026). Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus. Diabetes & Vascular Disease Research, 23(4). https://doi.org/10.1177/14791641251398558
Vancouver
Alakrab MS, Toumi D, Selmi A, Hajji A, Zoukar O, Abid S, et al. Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus. Diabetes & Vascular Disease Research. 2026;23(4). doi:10.1177/14791641251398558
BibTeX
@article{Alakrab2026,
author = {Alakrab, Manel Salsabil and Toumi, Dhekra and Selmi, Ameni and Hajji, Ahmed and Zoukar, Olfa and Abid, Salwa and Faleh, Raja and Kerkeni, Mohsen},
title = {Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus},
journal = {Diabetes & Vascular Disease Research},
year = {2026},
volume = {23},
number = {4},
doi = {10.1177/14791641251398558}
}
EUVIMED